vepoloxamer
Small moleculeexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT00113009)
Timeline
Indications
Mechanism of action
- Unspecified targetSurfactant
surfactant
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3137355 ↗
Also known as
- mst-188
- mst-188
- vepoloxamer
- vepoloxamer
- vepoloxamer
- vlts-934
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02646358 | Phase 1 | Jan 1, 2016 | Mast Therapeutics |
| NCT02596477 | Phase 2 | Oct 1, 2015 | Mast Therapeutics |
| NCT02449616 | Phase 3 | Jun 1, 2015 | Mast Therapeutics |
| NCT02093468 | Phase 2 | Jun 1, 2014 | Mast Therapeutics |
| NCT01737814 | Phase 3 | May 1, 2013 | Mast Therapeutics |
| NCT00113009 | Phase 2 | Mar 1, 2005 | Valentis |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mast Therapeutics | For profit | 5 | 5 | 3 | 2013 |
| Valentis | For profit | 1 | 1 | 1 | 2005 |
2 organizations
Page 1 / 1